-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2021 to Q2 2024.
- Prime Medicine, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$134K, a 532% decline year-over-year.
- Prime Medicine, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$108K, a 25.5% increase year-over-year.
- Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2023 was -$279K, a 70.6% increase from 2022.
- Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2022 was -$948K, a 95.1% decline from 2021.
- Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2021 was -$486K, a 126% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)